InvestorsHub Logo
Post# of 252343
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: DewDiligence post# 128959

Friday, 10/21/2011 12:58:28 PM

Friday, October 21, 2011 12:58:28 PM

Post# of 252343

I just read Feuerstein’s piece saying that VRUS might owe royalties to IDIX on its nuke IP, and I think there’s no substance to it. But this has nothing to do with the looming competition from ABT in all-oral HCV cocktails, which is presumably the reason for VRUS’ selloff today.




What do you find so appealing about ABT's all-oral offering?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.